These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 38203586)
1. Nephrotoxicity in the Age of Immune Checkpoint Inhibitors: Mechanisms, Diagnosis, and Management. Moturi K; Sharma H; Hashemi-Sadraei N Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203586 [TBL] [Abstract][Full Text] [Related]
3. Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition. Hakroush S; Kopp SB; Tampe D; Gersmann AK; Korsten P; Zeisberg M; Tampe B Front Immunol; 2020; 11():624547. PubMed ID: 33552089 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review. Sise ME; Seethapathy H; Reynolds KL Oncologist; 2019 Jun; 24(6):735-742. PubMed ID: 30902916 [TBL] [Abstract][Full Text] [Related]
5. The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand? Franzin R; Netti GS; Spadaccino F; Porta C; Gesualdo L; Stallone G; Castellano G; Ranieri E Front Immunol; 2020; 11():574271. PubMed ID: 33162990 [TBL] [Abstract][Full Text] [Related]
6. Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor-induced renal immune-related adverse events. Zheng K; Qiu W; Wang H; Si X; Zhang X; Zhang L; Li X Thorac Cancer; 2020 Jun; 11(6):1746-1751. PubMed ID: 32232975 [TBL] [Abstract][Full Text] [Related]
7. Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA. Kalinich M; Murphy W; Wongvibulsin S; Pahalyants V; Yu KH; Lu C; Wang F; Zubiri L; Naranbhai V; Gusev A; Kwatra SG; Reynolds KL; Semenov YR J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789879 [TBL] [Abstract][Full Text] [Related]
8. Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates. Singh S; Clemente LC; Parra ER; Tchakarov A; Yang C; Li Y; Long JP; Yee C; Lin JS Oncoimmunology; 2022; 11(1):2124678. PubMed ID: 36185804 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury. Sprangers B; Leaf DE; Porta C; Soler MJ; Perazella MA Nat Rev Nephrol; 2022 Dec; 18(12):794-805. PubMed ID: 36168055 [TBL] [Abstract][Full Text] [Related]
10. Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma. Ratanasrimetha P; Reddy VD; Kala J; Tchakarov A; Glass WF; Msaouel P; Lin JS Front Immunol; 2022; 13():898811. PubMed ID: 35967405 [TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibitors associated granulomatous small vessel vasculitis accompanied with tubulointerstitial nephritis: a case report. Tominaga K; Takeuchi K; Takakuma S; Sakamoto E; Hatanaka S; Kajimoto Y; Toda E; Terasaki Y; Kunugi S; Terasaki M; Shimizu A BMC Nephrol; 2023 Mar; 24(1):48. PubMed ID: 36894873 [TBL] [Abstract][Full Text] [Related]
12. Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study. Espi M; Teuma C; Novel-Catin E; Maillet D; Souquet PJ; Dalle S; Koppe L; Fouque D Eur J Cancer; 2021 Apr; 147():29-39. PubMed ID: 33607383 [TBL] [Abstract][Full Text] [Related]
14. Incidence, predictors and 6-month overall outcome of acute kidney injury in Chinese patients receiving PD-1 inhibitors. Qin Z; Liu K; Xu X; Li T; Ge Y; Wu B; Xing C; Mao H Future Oncol; 2022 May; 18(16):1951-1962. PubMed ID: 35232231 [TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritis. Miao J; Herrmann SM Clin Kidney J; 2023 Nov; 16(11):1834-1844. PubMed ID: 37915905 [TBL] [Abstract][Full Text] [Related]
16. Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors. Farooqui N; Zaidi M; Vaughan L; McKee TD; Ahsan E; Pavelko KD; Villasboas JC; Markovic S; Taner T; Leung N; Dong H; Alexander MP; Herrmann SM Kidney Int Rep; 2023 Mar; 8(3):628-641. PubMed ID: 36938084 [TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors and acute kidney injury. Zhou P; Gao Y; Kong Z; Wang J; Si S; Han W; Li J; Lv Z; Wang R Front Immunol; 2024; 15():1353339. PubMed ID: 38464524 [TBL] [Abstract][Full Text] [Related]
18. Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report. Hultin S; Nahar K; Menzies AM; Long GV; Fernando SL; Atkinson V; Cebon J; Wong MG BMC Nephrol; 2020 Sep; 21(1):391. PubMed ID: 32894101 [TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Inhibitor-Associated AKI: Debates in Diagnosis, Management, and Rechallenge. Seethapathy H; Herrmann SM; Rashidi A Semin Nephrol; 2022 Nov; 42(6):151346. PubMed ID: 37137187 [TBL] [Abstract][Full Text] [Related]
20. Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies. Belliere J; Mazieres J; Meyer N; Chebane L; Despas F Diagnostics (Basel); 2021 Jun; 11(7):. PubMed ID: 34208848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]